Arkolith/Insider Trading/OCUL/Form 4

Dugel Pravin

See Remarks, DirectorOCULAR THERAPEUTIX, INC (OCUL) · full profile →Form 4 · filed Nov 26, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$235K
Net Open-Market Flow
-$235K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 26, 2025Gift(G)50K—$0300K
Nov 26, 2025Gift(G)50K—$00
Nov 24, 2025Sell(S)20K$12.04$235K3.2M

Transaction Codes

G
Gift
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-116424) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML